about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersMultiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancerSexual factors and prostate cancerAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesAfter BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type XGenome-wide association studies identify four ER negative-specific breast cancer risk lociGenome-wide association study identifies novel breast cancer susceptibility lociThe clinical phenotype of Lynch syndrome due to germ-line PMS2 mutationsMultigene testing of moderate-risk genes: be mindful of the missenseThe androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersNo evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancerLog odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in AustraliaThe Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancerThe AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian womenCYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromePenetrance analysis of the PALB2 c.1592delT founder mutation.Androgenetic alopecia in men aged 40-69 years: prevalence and risk factorsELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancerIron-overload-related disease in HFE hereditary hemochromatosisLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairMultiple newly identified loci associated with prostate cancer susceptibilityColorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular featuresGenome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotypeA discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics servicesCandidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskCross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesUsing functional data analysis models to estimate future time trends in age-specific breast cancer mortality for the United States and England-WalesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSHormonal contraception increases risk of asthma among obese but decreases it among nonobese subjects: a prospective, population-based cohort studyRare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersRare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyRare mutations in XRCC2 increase the risk of breast cancerRare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening studyGenome-wide association study identifies new prostate cancer susceptibility lociLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis
P50
Q21144874-482B6257-9E58-4D66-A81F-8771D481FE41Q21144952-46294E83-2AD5-4FAF-BD66-99014CE7708EQ21999082-98A5980C-74B1-4E8C-8745-A53A0F427F32Q24531993-080221F4-A9F6-45B3-AEF9-E37F6BFE7BCBQ24535695-28F01D19-B598-46F1-971B-F6045D897231Q24618839-076B7798-A765-4AB1-BEF3-47FC37E7E2ACQ24622610-97BA24A7-92F3-459D-9BB6-512FCD7D4CFAQ24645441-DBB3E6EE-61ED-4E20-8C1C-401DF71FAA32Q24655454-C96F4D0A-229C-4E1B-8F39-7516AAB5CB3AQ24658557-88AB3D89-BBF8-477E-B49E-23E2B47342D1Q24797305-4F8B125A-85CA-4AD0-9692-FDD02916EF71Q24800108-F0BC1BC8-6415-4D56-8AB9-EE381A912BF2Q24802704-0B66DBE8-0F2A-4028-A969-98F604AA961EQ24806016-747DADC5-C89D-404D-8CBF-CE9E7F4A274BQ24806109-31C365CE-7707-49E1-8B32-0C787BD3BF9BQ24810265-2DE98502-0D4F-46CD-BFF2-B1E13340D57AQ24810733-4CEE65EC-3097-4411-AD19-4F315346A9E7Q26775022-E94C5715-841D-44C8-8822-A1B32BA6ACD8Q27851443-69C74C99-1A95-4B5E-B3DB-E50439743C71Q28191418-6A7E8A2C-2739-4719-A7EB-2C66D6072CEBQ28208394-E9881F1E-78F2-41CE-AE59-95990AB8D5A0Q28264901-657568D8-35D7-43A5-ABBA-F8642056521DQ28267893-4881EBB7-3195-45DE-B746-C957CB8DE4C3Q28268180-1A3E9972-6FDC-483A-916A-E1E521D952C6Q28284149-519221DC-1961-4A18-AFD9-00FD9937CDD2Q28305142-E07C6B2A-3CBB-42DE-817D-74344FAEBFECQ28384136-B67187D6-656A-4636-AE3C-D50465CB301FQ28385765-331CFC4E-87A7-413E-8C72-A898DA396082Q28388475-52C610C2-077C-410A-8556-BAE97A0E83CEQ28388497-58197747-7DD7-47F5-BC25-84355FD63317Q28394774-0D4CA7B1-FAD7-4B25-B319-6C5F4D8DB8E1Q28584533-AEAD702F-CB10-46C8-B150-59CFED25EF38Q28596814-40182604-6DE1-436E-A18F-68953B2BF054Q28652056-5B32D97D-B75A-49D1-8E95-DCF8344632C0Q28652308-F28CE005-49E4-446A-8E37-D119E046022EQ28730692-3DEFB377-8710-48CE-9D91-E23075A36BABQ28743906-656E974E-AEDA-4A92-B72C-E45AC600513DQ28924380-2938C973-DB29-4CA8-BB33-508807A6591DQ29416989-D18A7340-F625-4999-91F8-0C1E48209DDFQ29416993-E946CDBF-5345-42DE-96BA-E5E8D7884579
P50
description
forsker
@nb
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John L Hopper
@ast
John L Hopper
@nl
John L. Hopper
@da
John L. Hopper
@de
John L. Hopper
@en
John L. Hopper
@es
John L. Hopper
@fr
John L. Hopper
@nb
John L. Hopper
@nn
John L. Hopper
@sv
type
label
John L Hopper
@ast
John L Hopper
@nl
John L. Hopper
@da
John L. Hopper
@de
John L. Hopper
@en
John L. Hopper
@es
John L. Hopper
@fr
John L. Hopper
@nb
John L. Hopper
@nn
John L. Hopper
@sv
altLabel
John Hopper
@nb
John L Hopper
@en
prefLabel
John L Hopper
@ast
John L Hopper
@nl
John L. Hopper
@da
John L. Hopper
@de
John L. Hopper
@en
John L. Hopper
@es
John L. Hopper
@fr
John L. Hopper
@nb
John L. Hopper
@nn
John L. Hopper
@sv
P106
P1153
7201924128
P21
P31
P496
0000-0002-8567-173X